DTC Perspectives magazine recently announced its Second annual
Top DTC Marketers of the Year. But we gave it a slight spin, asking
to list the executives who have been recognized by DTC Perspectives
twice in a row. These marketers and PR professionals are the cream
of the crop working in direct-to-consumer (DTC) pharmaceutical
marketing. The DTC pharmaceutical marketing industry is a relative
pup age-wise, but these individuals are leading the way to growth.
If you're in the marketing communications field for pharmaceuticals
you might want to attend DTC National Conference March 25-27 at the
Boston Sheraton.
Tactics: Perception is all these days, so the onus is on PR pros
to convince consumers that D-T-C pharmaceutical marketing doesn't
raise drug prices. Drug companies spend a cool $3 billion annual on
advertising. "There are price controls in Europe, and some parts of
the world can't even afford drugs," says Bob Ehrlich, COO of Rx
Insight, which publishes DTC Magazine. "It costs the companies a
lot to have good drugs, but it's tough for the average American to
accept that." The remedy is to educate advocacy groups, members of
Congress and other influencers about the misconceptions connected
to drug prices - a debate that will rage in the years ahead along
with the graying of America.
The Top Marketers & Marcom Execs:
- Matthew Arm, Merck
- Sharon DeBacco, AstraZeneca
- Sharon Fairley, Pharmacia
- Sue Foelix, Aventis
- Lesa Henry, Wyeth
- Karen Lazan, Pfizer
- Doug Wilson, Lilly
- Dorothy Wetzel, Pfizer
For the top 25 winners in 2003, contact Jason Youner, Managing
Editor of DTC Perspectives at 973/328-9986 and/or http://www.dtcperspectives.com
or http://www.dtcnational.com